UPDATE: Morgan Stanley Downgrades Clorox on EPS Risk, Muted Long-Term Growth
October 17, 2013 at 10:19 AM EDT
In a report published Thursday, Morgan Stanley analyst Dara Mohsenian downgraded the rating on The Clorox Co. (NYSE: CLX ) from Equal-Weight to Underweight, but named an $83.00 price target. In the report, Morgan Stanley noted, “We are downgrading CLX to UW. Slowing US consumer spending and heightened competitive pressure
